🇺🇸 FDA
Pipeline program

Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists

CAPA001

Approved small_molecule active

Quick answer

Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists for Atrial Fibrillation is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Atrial Fibrillation
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials